Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loren L Flynn

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
F1000Research|June 6, 2019
Antisense-mediated splice intervention to treat human disease: the odyssey continuesIanthe Pitout, Loren L Flynn, Steve D Wilton, et al.
BMC Medicine|January 17, 2022
Short structural variants as informative genetic markers for ALS disease risk and progressionFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 TranscriptLoren L Flynn, Chalermchai Mitrpant, Ianthe L Pitout, et al.
International Journal of Molecular Sciences|August 26, 2022
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?Bradley Roberts, Frances Theunissen, Francis L Mastaglia, et al.
Frontiers in Neuroscience|December 24, 2019
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?Rita Mejzini, Loren L Flynn, Ianthe L Pitout, et al.
Biomedicines|June 2, 2021
Targeted <i>SMN</i> Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching StudiesLoren L Flynn, Chalermchai Mitrpant, Abbie Adams, et al.
International Journal of Molecular Sciences|October 17, 2019
Systematic Approach to Developing Splice Modulating Antisense OligonucleotidesMay T Aung-Htut, Craig S McIntosh, Kristin A Ham, et al.
International Journal of Molecular Sciences|August 10, 2024
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral SclerosisRita Mejzini, Marvin H Caruthers, Balazs Schafer, et al.
Frontiers in Neuroscience|February 22, 2020
Structural Variants May Be a Source of Missing Heritability in sALSFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
Neurology. Genetics|March 19, 2020
Association of a structural variant within the <i>SQSTM1</i> gene with amyotrophic lateral sclerosisJulia Pytte, Ryan S Anderton, Loren L Flynn, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
F1000Research|June 6, 2019
Antisense-mediated splice intervention to treat human disease: the odyssey continuesIanthe Pitout, Loren L Flynn, Steve D Wilton, et al.
BMC Medicine|January 17, 2022
Short structural variants as informative genetic markers for ALS disease risk and progressionFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 TranscriptLoren L Flynn, Chalermchai Mitrpant, Ianthe L Pitout, et al.
International Journal of Molecular Sciences|August 26, 2022
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?Bradley Roberts, Frances Theunissen, Francis L Mastaglia, et al.
Frontiers in Neuroscience|December 24, 2019
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?Rita Mejzini, Loren L Flynn, Ianthe L Pitout, et al.
Biomedicines|June 2, 2021
Targeted <i>SMN</i> Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching StudiesLoren L Flynn, Chalermchai Mitrpant, Abbie Adams, et al.
International Journal of Molecular Sciences|October 17, 2019
Systematic Approach to Developing Splice Modulating Antisense OligonucleotidesMay T Aung-Htut, Craig S McIntosh, Kristin A Ham, et al.
International Journal of Molecular Sciences|August 10, 2024
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral SclerosisRita Mejzini, Marvin H Caruthers, Balazs Schafer, et al.
Frontiers in Neuroscience|February 22, 2020
Structural Variants May Be a Source of Missing Heritability in sALSFrances Theunissen, Loren L Flynn, Ryan S Anderton, et al.
Neurology. Genetics|March 19, 2020
Association of a structural variant within the <i>SQSTM1</i> gene with amyotrophic lateral sclerosisJulia Pytte, Ryan S Anderton, Loren L Flynn, et al.
Pageof 2